NCT06036342View on ClinicalTrials.gov

Atrial Fibrillation Screening With MobiCARE in Subjects With Health Care Examination

Active, not recruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

April 25, 2022

Primary Completion Date

December 10, 2024

Study Completion Date

December 31, 2026

Conditions
Atrial Fibrillation
Interventions
DIAGNOSTIC_TEST

MobiCARE test

7-days continuous electrocardiography monitoring using MobiCARE device

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

lead

Seoul National University Hospital

OTHER